Neuro-Oncology Reviews

Volume 24 Number 12
30 June 2022

Home > Publications > Neuro-Oncology Reviews > Volume 24, Year 2022 > Number 12, 30 June

*

Osborn AG, Louis DN, Poussaint TY, Linscott LL, Salzman KL.
The 2021 World Health Organization Classification of Tumors of the Central Nervous System: What Neuroradiologists Need to Know.
AJNR Am J Neuroradiol. 2022 Jun 16→. doi: 10.3174/ajnr.A7462→. PMID: 35710121→. Review. ˍ

*

Prajapati HP, Kannaujia SK.
A simplified overview of the World Health Organization classification of central nervous system tumors 2021.
Surg Neurol Int. 2022 Jun 17;13:252→. doi: 10.25259/SNI_102_2022→. PMID: 35855126→. Review. ˍ

McMahon DJ, Gleeson JP, O'Reilly S, Bambury RM.
Management of newly diagnosed glioblastoma multiforme: current state of the art and emerging therapeutic approaches.
Med Oncol. 2022 Jun 18;39(9):129→. doi: 10.1007/s12032-022-01708-w→. PMID: 35716200→. Review˰ ˍ

Horbinski C, Berger T, Packer RJ, Wen PY.
Clinical implications of the 2021 edition of the WHO classification of central nervous system tumours.
Nat Rev Neurol. 2022 Jun 21→. doi: 10.1038/s41582-022-00679-w→. PMID: 35729337→. Review˰ ˍ

Balana C.
Optimal duration of adjuvant temozolomide in glioblastoma: An unsolved and unsolvable problem.
Neurooncol Pract. 2022 Jun 22;9(5):349-350→. doi: 10.1093/nop/npac054→. PMID: 36134019→. Comment˰ ˍ
Refers to: Gupta T, et al., Efficacy and safety of extended adjuvant temozolomide compared to standard adjuvant temozolomide in glioblastoma: Updated systematic review and meta-analysis.
Neurooncol Pract. 2022 May 7;9(5):354-363→. doi: 10.1093/nop/npac036→. PMID: 36134016→. Review, Meta-analysis. ˍ

Rallis KS, George AM, Wozniak AM, Bigogno CM, Chow B, Hanrahan JG, Sideris M.
Molecular Genetics and Targeted Therapies for Paediatric High-grade Glioma.
Cancer Genomics Proteomics. 2022 Jun 22;19(4):390-414→. doi: 10.21873/cgp.20328→. PMID: 35732328→. Review. ˍ

Ricciardi L, Manini I, Cesselli D, Trungu S, Piazza A, Mangraviti A, Miscusi M, Raco A, Ius T.
Carmustine Wafers Implantation in Patients With Newly Diagnosed High Grade Glioma: Is It Still an Option?
Front Neurol. 2022 Jun 23;13:884158→. doi: 10.3389/fneur.2022.884158→. PMID: 35812101→. Review, Meta-analysis. ˍ

Du X, He Y, Lin W.
Diagnostic Accuracy of the Diffusion-Weighted Imaging Method Used in Association With the Apparent Diffusion Coefficient for Differentiating Between Primary Central Nervous System Lymphoma and High-Grade Glioma: Systematic Review and Meta-Analysis.
Front Neurol. 2022 Jun 24;13:882334→. doi: 10.3389/fneur.2022.882334→. PMID: 35812103→. Review, Meta-analysis. ˍ

Evans M, Gill R, Bull KS.
Does a Bevacizumab-based regime have a role in the treatment of children with diffuse intrinsic pontine glioma? A systematic review.
Neurooncol Adv. 2022 Jun 24;4(1):vdac100→. doi: 10.1093/noajnl/vdac100→. PMID: 35821674→. Review. ˍ

Sener U, Ruff MW, Campian JL.
Immunotherapy in Glioblastoma: Current Approaches and Future Perspectives.
Int J Mol Sci. 2022 Jun 24;23(13):7046→. doi: 10.3390/ijms23137046→. PMID: 35806051→. Review. ˍ

El-Abtah ME, Talati P, Dietrich J, Gerstner ER, Ratai EM.
Magnetic resonance spectroscopic imaging for detecting metabolic changes in glioblastoma after anti-angiogenic therapy-a systematic literature review.
Neurooncol Adv. 2022 Jun 27;4(1):vdac103→. doi: 10.1093/noajnl/vdac103→. PMID: 35892047→. Review. ˍ

Pirozzi M, Caterino M, Facchini S, Zotta A, Messina G, Rauso R, Sica A, Sciano D, Facchini G, Orditura M, Somma T, Maiuri F, Cappabianca P, Ciardiello F, Fasano M.
Regorafenib beyond the Second Line in Relapsed Glioblastoma: A Case Report and Literature Review.
Case Rep Oncol. 2022 Jun 27;15(2):642-647→. doi: 10.1159/000524954→. PMID: 35949909→. Case report, Review. ˍ

Di Nunno V, Fordellone M, Minniti G, Asioli S, Conti A, Mazzatenta D, Balestrini D, Chiodini P, Agati R, Tonon C, Tosoni A, Gatto L, Bartolini S, Lodi R, Franceschi E.
Machine learning in neuro-oncology: toward novel development fields.
J Neurooncol. 2022 Jun 28→. doi: 10.1007/s11060-022-04068-7→. PMID: 35761160→. Review˰ ˍ

Li AY, Iv M.
Conventional and Advanced Imaging Techniques in Post-treatment Glioma Imaging.
Front Radiol. 2022 Jun 28;2:883293∟. doi: 10.3389/fradi.2022.883293∟. PMID: 37492665∟. Review. ˍ

Galijasevic M, Steiger R, Mangesius S, Mangesius J, Kerschbaumer J, Freyschlag CF, Gruber N, Janjic T, Gizewski ER, Grams AE.
Magnetic Resonance Spectroscopy in Diagnosis and Follow-Up of Gliomas: State-of-the-Art.
Cancers (Basel). 2022 Jun 29;14(13):3197→. doi: 10.3390/cancers14133197→. PMID: 35804969→. Review. ˍ

Rodríguez-Camacho A, Flores-Vázquez JG, Moscardini-Martelli J, Torres-Ríos JA, Olmos-Guzmán A, Ortiz-Arce CS, Cid-Sánchez DR, Pérez SR, Macías-González MDS, Hernández-Sánchez LC, Heredia-Gutiérrez JC, Contreras-Palafox GA, Suárez-Campos JJE, Celis-López MÁ, Gutiérrez-Aceves GA, Moreno-Jiménez S.
Glioblastoma Treatment: State-of-the-Art and Future Perspectives.
Int J Mol Sci. 2022 Jun 29;23(13):7207→. doi: 10.3390/ijms23137207→. PMID: 35806212→. Review. ˍ

Vuong HG, Dunn IF.
Primary versus secondary gliosarcoma: a systematic review and meta-analysis.
J Neurooncol. 2022 Jun 29→. doi: 10.1007/s11060-022-04057-w→. PMID: 35768633→. Review, Meta-analysis˰ ˍ

Al Sharie S, Talafha M, Abu Laban D, Al Awabdeh T, Al-Mousa A, Al-Masri N, Al-Hussaini M.
H3 K27M-mutant diffuse midline glioma with osseous metastases: A case report and a literature review.
Clin Neuropathol. 2022 Jun 30→. doi: 10.5414/NP301475→. PMID: 35770519→. Case report, Review˰ ˍ

Cruz JVR, Batista C, Afonso BH, Alexandre-Moreira MS, Dubois LG, Pontes B, Moura Neto V, Mendes FA.
Obstacles to Glioblastoma Treatment Two Decades after Temozolomide.
Cancers (Basel). 2022 Jun 30;14(13):3203→. doi: 10.3390/cancers14133203→. PMID: 35804976→. Review. ˍ

Giustozzi M, Proietti G, Becattini C, Roila F, Agnelli G, Mandalà M.
ICH in patients with primary or metastatic brain cancer treated or not with anticoagulants: a systematic review and meta-analysis.
Blood Adv. 2022 Jun 30:bloodadvances.2022008086→. doi: 10.1182/bloodadvances.2022008086→. PMID: 35772127→. Review, Meta-analysis. ˍ

Prajapati HP, Ansari A.
Updates in the Management of Recurrent Glioblastoma Multiforme.
J Neurol Surg A Cent Eur Neurosurg. 2022 Jun 30→. doi: 10.1055/s-0042-1749351→. PMID: 35772723→. Review˰ ˍ

*

Sejda A, Grajkowska W, Trubicka J, Szutowicz E, Wojdacz T, Kloc W, Iżycka-Świeszewska E.
WHO CNS5 2021 classification of gliomas: a practical review and road signs for diagnosing pathologists and proper patho-clinical and neuro-oncological cooperation.
Folia Neuropathol. 2022 Jun 30;60(2):137-152→. doi: 10.5114/fn.2022.118183→. PMID: 35950467→. Review. ˍ

Smith KA, Hendricks BK, DiDomenico JD, Conway BN, Smith TL, Azadi A, Fonkem E.
Ketogenic Metabolic Therapy for Glioma.
Cureus. 2022 Jun 30;14(6):e26457→. doi: 10.7759/cureus.26457→. PMID: 35923675→. Review. ˍ